Pharmacokinetics of acute and sub-chronic aripiprazole in P-glycoprotein deficient mice

This publication has 34 references indexed in Scilit:

• Venlafaxine induces P‐glycoprotein in human Caco‐2 cells
  Human Psychopharmacology: Clinical and Experimental, 2006
• Associations between MDR1 gene polymorphisms and schizophrenia and therapeutic response to olanzapine in female schizophrenic patients
  Journal of Psychiatric Research, 2006
• Hypericum perforatum: Which Constituents may Induce Intestinal MDR1 and CYP3A4 mRNA Expression?
  Planta Medica, 2006
• THE IMPACT OF P-GLYCOPROTEIN ON THE DISPOSITION OF DRUGS TARGETED FOR INDICATIONS OF THE CENTRAL NERVOUS SYSTEM: EVALUATION USING THE MDR1A/1B KNOCKOUT MOUSE MODEL
  Drug Metabolism and Disposition, 2005
• The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry
  Pharmacopsychiatry, 2004
• Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor
  European Journal of Pharmacology, 2002
• Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
  Proceedings of the National Academy of Sciences, 2000
• Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.
  Molecular and Cellular Biology, 1990
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
  Proceedings of the National Academy of Sciences, 1989